Atom Investors’s Cymabay Therapeutics CBAY Stock Holding History

Atom Investors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,070	Closed	-$214K	–	691
2023 Q4	$214K	Sell	9,070 -15,468	-63%	-$275K	0.04%	397
2023 Q3	$366K	Buy	+24,538	New	+$325K	0.08%	285
2020 Q4	–	Sell	-21,477	Closed	-$155K	–	613
2020 Q3	$155K	Buy	+21,477	New	+$115K	0.01%	429

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Atom Investors's CBAY Position: Q1 2024 in Review

Atom Investors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 9,070 shares — an estimated $214K sold.

Atom Investors first reported a position in CBAY in Q3 2020 and held it in 3 quarters. The position peaked at $366K in Q3 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Atom Investors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Atom Investors sold 9,070 Cymabay Therapeutics shares in Q1 2024, an estimated $214K.
Atom Investors first reported a position in Cymabay Therapeutics in Q3 2020 and held it in 3 quarters.
Atom Investors's Cymabay Therapeutics position peaked at $366K in Q3 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Atom Investors's 13F filing for Q1 2024, filed 15 May 2024.